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Abstract  
Lymphoid leukemia (LL) and lymphoma are two groups of blood cancers developed from 
lymphoid cells (LCs). To understand the cause and the mechanism of cell transformation of a 
LC, we studied the potential sources of cell injuries of LCs and analyzed how DNA changes 
are generated and accumulate in LCs. I. The DNA changes that contribute to cell 
transformation of a LC can be generated in the LCs in bone marrow, thymus, lymph nodes 
(LNs), and/or lymphoid tissues (LTs). In LNs and LTs, repeated pathogen-infections may be 
the main cause for cell injuries and DNA injuries of LCs. In marrow cavity, repeated bone-
remodeling during bone-growth and bone-repair, by producing toxic substances, may be a 
source of damage to hematopoietic cells, including hematopoietic stem cells (HSCs) and 
developing LCs. In thymus, thymic involution and death of stromal cells may be a damaging 
factor for the developing T-cells. II. Point DNA mutation (PDM) and chromosome change 
(CC) are the two major types of DNA changes. CCs include numerical CCs (NCCs) and 
structural CCs (SCCs). Generation of PDM is often a result of Misrepair of DNA on a double-
strand DNA break. Generation of NCC is rather a consequence of dysfunction of cell division 
promoted by damage. Generation of SCC may be a result of Misrepair of DNA on multiple 
DNA breaks. DNA breaks in a LC can be introduced not only by external damage, but also 
possibly by DNA rearrangements of Ig/TCR genes. III. Repeated cell injuries and repeated 
cell proliferation drive accumulation of DNA changes in LCs and HSCs. However, long-term 
accumulation of DNA changes occurs mainly in long-living stem cells including HSCs and 
memory cells. In conclusion, the DNA changes in LCs are generated and accumulate as a 
consequence of repeated cell injuries and repeated cell proliferation; and three potential 
sources of cell injuries of LCs may be: repeated bone-remodeling, long-term thymic 
involution, and repeated pathogen-infections.  
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I. Introduction 
Lymphoid leukemia (LL) and lymphoma are two large groups of blood cancers developed 
from lymphoid cells (LCs). Differently from most solid tumors, blood cancers can occur in 
young children. Some forms of leukemia and lymphoma such as acute lymphoblastic 
leukemia (ALL) and Burkitt lymphoma (BL) have higher incidences in children than in adults. 
For understanding pediatric LL and lymphoma, we have made a profound analysis on the 
causes and the mechanism of transformation of a LC. Our analysis was driven by the 
following questions:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What are the causes for cell injuries of 
lymphoid cells (LCs) in bone marrow, 
thymus, and lymph nodes, respectively? 
 
 
Why do lymphoid leukemia (LL) 
and lymphoma occur in children? 
 
Why can a LC be transformed 
more rapidly than a tissue cell? 
 
 
 Is a LC different from a tissue 
cell on transformation? 
What a type of DNA changes is 
associated with the rapider 
cell transformation of a LC? 
 
 
Does a LC have 
higher tolerance to 
DNA changes than a 
tissue cell? 
Does a LC require obtaining 
fewer cancerous properties 
for transformation than a 
tissue cell?  
Is it possible that the 
rapider cell transformation 
of a LC is made by a great-
effect chromosome change?  
Is it possible that the bone 
remodeling and the thymic 
involution are related to cell 
injuries of LCs?  
In paper A 
(Hypothesis 1) 
In paper C: interpretation of pediatric forms of lymphoid leukemia by our hypotheses 
In paper D: interpretation of pediatric forms of lymphomas by our hypotheses 
In paper B (Hypothesis 2) 
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We will introduce our analysis and our hypotheses in four papers, namely: paper A (Three 
potential sources of cell injuries of lymphoid cells associated with development of lymphoid 
leukemia and lymphoma (the present paper)), paper B (Three pathways of cell transformation 
of lymphoid cell: a slow, a rapid, and an accelerated), paper C (Acute lymphoblastic 
leukemia may develop as a result of rapid transformation of a lymphoblast triggered by 
repeated bone-remodeling during bone-growth), and paper D (Pediatric lymphoma may 
develop by “one-step” cell transformation of a lymphoid cell). 
In the present paper, we discuss the potential sources of cell injuries of LCs and analyze how 
DNA changes are generated and accumulate in LCs.  In general, LL arises from a LC 
transformed in bone marrow, and lymphoma arises from a LC transformed in a lymph node 
(LN) or a lymphoid tissue (LT). However, because of the recirculation of LCs in bloodstream 
and lymph, some of the DNA changes that contribute to lymphoma development may be 
generated in precursor HSCs or LCs in marrow; and some DNA changes that contribute to LL 
development may be generated in a LC in a LN/LT. Therefore, it is useful to study LL and 
lymphoma together on their causes and their developing mechanisms. “Lymphoid cells 
(LCs)” include all the cells of lymphoid lineage in marrow, bloodstream, LNs, and LTs. The 
term “lymphocytes” is referred to specifically the naïve lymphocytes (Steven, 2016). We aim 
to show by our discussion that, the DNA changes in LCs are generated and accumulate as a 
consequence of repeated cell injuries; and three potential sources of cell injuries of LCs are: 
repeated bone-remodeling, long-term thymic involution, and repeated pathogen-infections.  
 
We use the following abbreviations in this paper: 
 
ALCL: anaplastic large cell lymphoma 
ALL: acute lymphoblastic leukemia 
AML: acute myeloid leukemia 
ATLL: adult T-cell lymphoma/leukemia 
APC: antigen-presenting cell 
BL: Burkitt lymphoma 
CC: chromosomal change 
CLL: chronic lymphocytic leukemia 
DLBCL: diffuse large B-cell lymphoma 
EBV: Epstein-Barr virus  
FL: follicular lymphoma 
GC: germinal center 
HC: hematopoietic cells 
HIV: human immunodeficiency virus 
HLTV-1: human T-cell lymphotropic virus type 1 
HSC: hematopoietic stem cell 
LC: lymphoid cell 
LN: lymph node 
LT: lymphoid tissue 
MALTL: mucosa-associated lymphoid tissue 
lymphoma  
MC: myeloid cell 
MCL: mantle cell lymphoma  
MDS: myelodysplastic syndrome 
NCC: numerical chromosome change 
NHL: non-Hodgkin’s lymphoma  
PDM: point DNA mutation 
SCC: structural chromosome change  
TCR: T-cell receptor
 
II. Development of lymphoid cells (LCs) in marrow cavity and in thymus 
After birth, all of our blood cells including LCs and myeloid cell (MCs) are produced by the 
hematopoietic stem cells (HSCs) in marrow.  Bone marrow is a spongy tissue stored in the 
marrow cavity and the spongy part of a bone. Hematopoietic cells in bone marrow are a 
mixture of cells of different lineages and at different developing stages. They include HSCs, 
progenitor cells, blast cells, pro-cytes, and mature blood cells (Figure 1). Every day, about 
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10
11
 of new red cells and 10
8
 of new lymphocytes are produced in a human. For producing 
such huge number of cells, hematopoietic system needs to work constantly. In any moment, a 
large number of hematopoietic cells are in processes of cell division and cell differentiation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Development of lymphoid cells in bone marrow and in thymus 
Hematopoietic stem cells (HSCs) are the stem cells for all types of blood cells. For hematopoiesis, a HSC needs 
to produce a progenitor cell by asymmetrical cell division. There are two types of progenitor cells: myeloid 
progenitor cells (MPCs) and lymphoid progenitor cells (LPCs). MPCs are the precursor cells for all the cells in 
myeloid lineage, including red cell, neutropjils, eosinophils, basophils, monocytes, and platelets. LPCs are the 
precursor cells for all the cells in lymphoid lineage, including T-cells, B-cells, and natural killer cells. Except T-
cells, all types of blood cells are fully developed in bone marrow. T-cells develop in thymus from a LPC 
produced in marrow but migrated to thymus. Once produced, the progenitor cells proliferate rapidly and 
differentiate into blast cells in different lineages, such as myeloblasts, monoblasts, and lymphoblasts. A blast 
cell continues to proliferate and differentiate into one or more types of pro-cytes, such as pro-myelocytes 
(neutrophilic, basophilic, or eosinophilic), pro-monocytes, and pro-lymphocytes. A pro-cyte divides several 
times and produces mature cells of the same type.  
 
2.1  Hematopoietic stem cells (HSCs): multi-potent and self-renewable  
HSCs are the ancestors for all hematopoietic cells and all blood cells. A general process of 
hematopoiesis is as follows: A. a HSC produces a progenitor cell; B. the progenitor cell then 
proliferates rapidly to produce a large number of blast cells in different lineages; C. a blast 
cell then proliferates and differentiates into different groups of pro-cytes (immature cells); and 
D. a pro-cyte then divides for several times to become mature cells (Figure 1). HSCs account 
Hematopoietic stem cell (HSCs) 
Different types of blast cells  
Myeloid progenitor cells (MPCs) 
Different types of Pro-cytes  
             Mature myeloid cells                                       
(Red cell, neutrophils, eosinophils, 
basophils, monocytes, and platelets) 
In bone marrow  In thymus  
T-lymphoblasts  
          Mature T-cells                        
(CD4+ cells and CD8+ cells) 
T-pro-lymphocytes 
B-lymphoblasts 
Lymphoid progenitor cells (LPCs) 
B-pro-lymphocytes 
 Mature B-cells  
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for only 0.001% of hematopoietic cells, but they can regenerate for maintaining their number. 
A HSC has the potential of self-renewal for our whole lifetime. By symmetrical cell division, 
a HSC produces two daughter HSCs. By asymmetrical cell division, a HSC gives rise to two 
different cells:  a new HSC and a progenitor cell. Two major types of progenitor cells are 
myeloid progenitor cells (MPCs) and lymphoid progenitor cells (LPCs). MPCs are the 
ancestors for all the cells in myeloid lineage, including granulocytes (neutrophiles, basophiles, 
and eosinophiles), monocytes, erythrocytes (red cells), and megakaryocytes (platelets). LPCs 
are the ancestors for all the cells in lymphoid lineage, including T-cells, B-cells, and natural 
killer (NK) cells. In a normal marrow, 55% of nucleated cells are of granular lineage, 20% are 
of erythrocytic lineage, and 20% are LCs. 
Since HSCs are the unique source of new blood cells, an abnormality on the number or on the 
functionality of HSCs may lead to a severe disease. For example, if regeneration of HSCs is 
disturbed by damage or by a genetic disorder, blood cells cannot be sufficiently produced, and 
aplastic anemia may occur. If a HSC is transformed by DNA changes, accumulation of 
abnormal HSCs may affect hematopoiesis. It is reported that the background DNA mutations 
in HSCs are related to the clonal hematopoiesis in old people (Shlush, 2015).  HSCs are 
multi-potent and regenerable for our whole lifetime. Therefore, transplantation of autologous 
or allogeneic HSCs is an important replacing treatment in some malignant diseases, including 
leukemia, aplastic anemia, and myelodysplastic syndrome (MDS).  
2.2 Progenitor cells and lymphoblasts: oligo-potent, proliferative, and immature on cell 
functions 
Progenitor cell is the ancestor cell for one lineage of cells. For example, MPC is for myeloid 
lineage and LPC for is for lymphoid lineage. MPCs and LPCs are also self-regenerable, but 
only for some generations. Once produced, a progenitor cell proliferates and differentiates 
into different types of blast cells. For example, a MPC differentiates into megakaryoblasts, 
erythroblasts, myeloblasts, and monoblasts. A LPC differentiates into T-lymphoblasts and B-
lymphoblasts. A blast cell then proliferates and differentiates into one or more types of pro-
cytes. For example, a myeloblast will differentiate into three types of pro-myelocytes: 
neutrophilic, basophilic, or eosinophilic (Figure 1). A lymphoblast will differentiate into pro-
lymphocytes. Lymphoblasts can be identified by specific cell surface markers such as CD10 
and TdT. Lymphoblasts express intracellular IgM but not membrane IgM (mIgM).  Except T-
cells, all types of blood cells are fully developed in marrow. T-cells develop in thymus, from a 
LPC produced in marrow but migrated to thymus.  
Progenitor cells and blast cells have three characteristics: oligo-potent, proliferative, and 
immature on cell functions.  Thus, these cells have a risk of DNA injuries during DNA 
synthesis and cell division by damaging factors. If cell differentiation of one of these cells is 
altered by DNA changes, hematopoiesis can be severely affected. For example, when cell 
differentiation of a MPC is altered, MDS may occur. Failure of cell differentiation of a 
lymphoblast may result in occurrence of ALL.  
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2.3  DNA rearrangement of Ig/TCR genes in lymphoblasts 
Lymphoblasts are the precursors of pro-lymphocytes and naïve lymphocytes. A naïve 
lymphocyte expresses membrane immunoglobulin (Ig) (on B-cell) or T-cell receptor (TCR, 
on T-cell). However, the molecules of Ig or TCR on different lymphocytes are different by the 
ligand (antigen)-binding part. This is a result of DNA rearrangement of Ig/TCR genes during 
differentiation of lymphoblasts (Chowdhury, 2004; Thomas, 2009).  In human B-cells, an Ig 
protein has two identical heavy chains and two identical light chains. Each chain has a 
variable region. The variable region is coded by a gene composed of two or three of the 
following DNA segments: variable (V) segment, joining (J) segment, and divers (D) segment. 
A gene for the variable region of heavy chain is composed by V-D-J, and that for light chain 
is made by V-J. In fact, in locus of Ig genes (14q32) in B-lymphoblasts, there are many 
candidate segments for VH, DH, and JH, respectively.  For example, in human being, there are 
51 (65) VH-segments, 6 JH-segments, and 27 DH-segments for heavy chain, and there are 40 
(70?) VL-segments and 5 JL-segments for light chain (Berg, 2002; Janeway, 2001; Jung, 2006).  
DNA rearrangement of Ig gene is a process of recombining randomly one of VH-segments, 
one of JH-segments, and one of DH-segments in locus of Ig gene, and cutting off other 
unneeded segments. By this process, each cell will have only one gene (V-D-J) for the 
variable region of heavy chain and one gene (V-J) for light chain. As a result of random 
recombination of V, J, and D segments, the final genes of Ig are different in different cells. 
The diversity of genes for the variable region of heavy chain is thus 51 (VH) x 6 (JH) x 27 (DH) 
= 8262, and that for light chain is 40 (VL) x 5 (JL) = 200. An Ig molecule has two identical 
heavy chains and two identical light chains, thus an Ig has totally two different variable 
regions. The diversity of Ig is thus 51 (VH) x 6 (JH) x 27 (DH) x 40 (VL) x 5 (JL) = 1652400.  
Probably, the Ig molecules produced by different naïve lymphocytes are distinct from each 
other on the antigen-binding part. DNA rearrangement of Ig gene increases largely the 
diversity of Ig molecules of B-cells. A large diversity of Ig molecules permits B-cells to 
recognize antigens in large diversity and produce antibodies in large diversity. 
2.4  Pro-lymphocytes: uni-potent, proliferative, in large number, and immature  on cell 
functions   
Pro-cytes have higher degree of cell differentiation and maturation than blast cells, but they 
are not yet fully developed. Pro-cytes are proliferative but uni-potent (Figure 1). Each pro-
cyte will differentiate into a number of mature cells of the same type. For example, a pro-
lymphocyte develops into a number of mature (naïve) lymphocytes. Pro-lymphocytes can 
produce membrane Ig (mIg). Pro-lymphocytes can be distinguished from lymphoblasts and 
mature lymphocytes by specific surface markers including CD19, MCH (II), and CD20. 
CD10 and TdT are not expressed on pro-lymphocytes. The total number of pro-cytes may be 
much higher than that of blast cells, because a blast cell needs to divide several times to 
develop into pro-cytes.  Thus pro-cytes may account for the largest part of immature 
nucleated cells in marrow. Since pro-lymphocytes are proliferative, they have also high risk of 
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cell injuries during DNA synthesis and cell division. ALL and AML may arise also from pro-
cytes, respectively from pro-lymphocyte and pro-myelocyte.  
2.5    Naive lymphocytes: small, non-proliferative, and mature on cell functions  
For distinguishing the new mature lymphocytes from the activated mature LCs (immune 
cells), we call the new-born mature LCs as “naïve lymphocytes”. B-cells develop fully in 
marrow whereas T-cells develop in thymus. Naive lymphocytes will enter bloodstream and 
then lymph system. Part of them will be stored in spleen and LNs. Naïve lymphocytes are 
characterized by expression of mIgM and mIgD. Being non-proliferative, naive lymphocytes 
may have lower risk of DNA injuries and DNA mutations than lymphoblasts and pro-
lymphocytes. Naïve lymphocytes are the smallest cells in our body. They have normal-sized 
nucleus but little cytoplasm. This suggests that a naïve lymphocyte produces much fewer 
intracellular proteins than other cells. 
2.6  Development of T-cells in thymus 
Thymus is an organ located anterior and superior the mediastinum between two lungs. This 
organ is made by two types of tissues: thymic stroma and hematopoietic cells. The 
hematopoietic cells are mainly developing T-cells, called also thymocytes. Thymic stromal 
cells include epithelial cells and dendritic cells. Stromal cells are important in the 
development of T-cells, because they provide a special microenvironment for selecting 
functional and self-tolerant T-cells (Nitta, 2016). Thymus has the largest size in late childhood 
(age 11-13), but it starts to shrink since age of puberty. Atrophy of thymus occurs mainly to 
thymic stroma, in which stromal cells are gradually replaced by fat tissues. Finally in an adult, 
thymus is made by some tiny islands hidden in fat tissues. Despite of thymic involution, T-
cell hematopoiesis continues throughout our whole lifetime. 
Thymus has two parts of structures: the cortex and the medulla. The cortex is the location for 
early events of T-cell development, including TCR gene rearrangement and positive selection 
of T-cells. The medulla is the location for later events of T-cell development, including 
negative selection of T-cells. Positive selection is to select the functional T-lymphoblasts, 
namely the lymphoblasts that can recognize self-MHC (major histocompatibility complex) 
presented by epithelial cells. Negative selection is for removing the auto-reactive T-cells, 
namely the T-cells that interact with the peptides presented by thymic dendritic cells. On cell 
functions, mature T-cells have two groups: CD4+ T-cells and CD8+ T-cells. CD4+ cells and 
CD8+ cells will be activated in LNs/LTs to develop respectively into T-helper cells (Th cells) 
and cell-toxic T-lymphocytes (CTLs). 
TCR determines the antigen specificity of a T-cell. A large diversity of TCR enables T-cells 
to recognize antigens in large diversity. A TCR molecule has two chains: α chain and β chain. 
In some cases, TCR is composed by γ chain and δ chain. Similar to that in B-cells, DNA 
rearrangements of genes of α chain (locus: 14q11.2) and β chain (locus: 7q34) of TCR occur 
in T-lymphoblasts (Thomas, 2009; Janeway, 2001). The variable region of each chain is 
coded by a gene composed of two or three DNA segments (V-, D-, and J-segments): V-J for α 
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chain and V-D-J for β chain. By DNA rearrangement of TCR gene, different T-cells will 
express different TCRs, which have different affinities to an antigen.  
III. Activation of naïve lymphocytes by pathogens in a lymph node (LN) or 
lymphoid tissue (LT) 
Naïve lymphocytes will enter lymphatic system to be activated and then transported to all 
organs. Lymphatic system is part of immune system distributing all over our body. This 
system is composed of lymphatic organs, lymph vessels, lymph, and LCs. In human being, 
lymphatic organs include bone marrow, thymus, spleen, tonsil, LNs, and low-concentrated 
LTs. Lymph vessels are the tubes for connecting lymphatic organs and conducting lymph 
fluid from LN to LN and finally into bloodstream. Lymphatic system plays three roles in 
immunity: trapping and removing pathogens in LNs; activating lymphocytes by pathogens in 
a LN/LT, and conducting lymphocyte-recirculation in bloodstream and lymph.  
3.1  Structure and functions of a LN  
About 600 LNs distribute throughout our body. A LN has two parts of structures: the outer 
cortex and the inner medulla. Naïve B-cells are stored in the superficial part of cortex and 
mostly in the mantle zones of follicles. Activation of a B-cell takes place inside a follicle in 
deep part of cortex. T-cells are stored and activated in center of paracortical zone. B-cells and 
T-cells can be distinguished by some cell markers: CD20, CD79a, and PAX5 are specific for 
B-cells; and CD5 is specific for T-cells. The LCs in bloodstream enter a LN via high 
endothelial venues. A LN has two functions: A. activation of naïve lymphocytes by pathogens 
and production of antigen-specific immune cells; and B. filtration and clearance of pathogens 
and foreign substances in lymph. In a LN, there are not only B-cells and T-cells but also other 
types of immune cells including dendritic cells, granulocytes, macrophages, and NK cells. 
These innate immune cells can recognize pathogens and foreign substances in lymph and 
remove them. Dendritic cells are antigen-presenting cells (APCs), and they play an important 
role in activation of B-cells and T-cells.   
Low-concentrated LT is a loose organization of lymphocytes in part of a tissue. It is 
composed by B-cells and T-cells, but it does not have fixed structure and capsule. In a LT, 
there are M-cells, which function as antigen-presenting cells. An M-cell can trap and present 
antigens to Th cells for activating B-cells and T-cells. LTs distribute widely in skin, mucosa 
of digestive tract and airway wall, and the capsules of an organ. In mucosal LT, T/B-cells are 
located in sub-epithelium, but M-cells are located between epithelial cells.  In skin and 
capsules of organs, LTs distribute not only in sub-epithelium and but also around dermal 
veins (Ono, 2015; Nomura, 2014). The peri-vascular LCs may function as a barrier to prevent 
the invasion of pathogens from infected tissues into bloodstream and that from bloodstream 
into tissues. 
3.2  Activation and differentiation of B-cells into immune cells in a LN 
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Activation of a naïve lymphocyte by pathogens is a complex process. Here we give only a 
brief introduction of this process.  Activation of a B-cell takes place in a follicle in superficial 
cortex, and activation of a T-cell occurs in the paracortical zone. The activation of a naive 
lymphocyte by the primary contact with an antigen presented by APC is called primary 
immune response. By primary response, a naïve lymphocyte differentiates into a large number 
of antigen-specific immune cells, including effector cells and memory cells. Plasma cells are 
effector B-cells, which can produce antigen-specific antibodies in LNs and in affected tissues. 
Th cells and CTLs are effector T-cells. Effector cells and memory cells will be transported to 
all organs via lymph and bloodstream to take part in adaptive immunoreactions in infected 
tissues. When a memory cell contacts again the same type of antigen, it will be activated 
quickly and produce again a large number of effector cells and memory cells. This process is 
called secondary immune response.  
Activation of B-cell needs two signals: binding of B-cell receptor (mIg) to an antigen 
presented by APC and interacting of the B-cell with a Th cell. Upon antigen-activation, B-
cells proliferate quickly and the produced cells compose a germinal center (GC) in a follicle. 
The size of GC is enlarged gradually with the increasing of number of cells. Figure 2 shows a 
general process of activation and differentiation of a B-cell in a LN. In primary response, a B-
cell proliferates and differentiates firstly into centroblasts. A centroblast then proliferates and 
differentiates into a large number of centrocytes. Centrocytes are then selected by antigen-
affinity through interacting with two cells: follicular antigen-presenting dendrite cells and Th 
cells. The centrocyte that has the highest antigen-affinity (mIg-antigen affinity) will continue 
differentiation and finally develop into immunoblasts. Other centrocytes will undergo 
apoptosis (Figure 2). An immunoblast then differentiates into two types of cells: plasmablasts 
and memory B-cells. A plasmablast will proliferate and produce a large number of plasma 
cells.  
During activation of B-cell, the B-cells in different differentiating stages have different 
morphologies and distribute in different areas of a GC (Janeway, 2001). For example, naïve 
B-cells are small cells distributing in the mantle zone of GC.  Centroblasts are mediate-sized 
cells distributing in the dark zone of GC. Since centroblasts are proliferative, they are 
basophilic and have blue color in hematoxyline-eosin (HE) staining. Centrocytes are small 
cells located in center (light zone) of GC. Centroblasts can be distinguished from centrocytes 
also by the shape of nucleus: the former have non-cleaved nucleus whereas the latter have 
cleaved nucleus. Immunoblasts differentiate into plasmablasts and memory cells in the cap 
zone of GC. Immunoblasts are large round cells but plasmablasts are large egg-shaped cells 
(Figure 2). Memory B-cells are small cells distributing in the marginal zone of a follicle. 
Plasma cells are large egg-shaped cells stored in medullary cords.  
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Figure 2. Activation and differentiation of B-cells in primary and secondary immune responses 
Activation of a naive lymphocyte by primary contact with an antigen is called primary immune response. In 
primary response, a naïve lymphocyte proliferates and differentiates into a large number of antigen-specific 
immune cells, including effector cells and memory cells. When a memory cell contacts again the same type of 
antigen, the cell will be activated quickly and produce again a large number of effector cells and memory cells. 
This process is called secondary immune response. Activation of a B-cell takes place in a follicle. Upon 
activation by an antigen, a B-cell proliferates and differentiates firstly into centroblasts. A centroblast then 
proliferates and differentiates into a large number of centrocytes. The centrocyte that express the highest 
antigen-affinitive mIgs will differentiate into immunoblasts. Other centrocytes will undergo apoptosis. An 
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immunoblast then differentiates into plasmablasts and memory B-cells. Memory B-cells and plasmablasts will 
be transported to all organs via lymph and bloodstream. A plasmablast can proliferate and produce a large 
number of plasma cells, which will produce antibodies.  
 
3.3 Somatic hypermutation and class-switching recombination of Ig genes in B-cells 
During activation of a B-cell, somatic hypermutation of Ig genes takes place in centroblasts. 
Hypermutation occurs to the part of DNA that codes the variable region of heavy or light 
chain of Ig protein. This process is triggered by an enzyme, namely the activation-induced 
deaminase (AID) (Dudley, 2005). By deaminating, AID can transform a bases-C in a strand of 
DNA into a uracil (base-U). When a base-C is converted into base-U, the double strands of 
DNA are not any more complementary (base U- base G) at this point. Then, the “head” (the 
part for pairing) of base-U is removed, leaving the base-G in complementary strand 
suspending in non-matching state.  In subsequent DNA replications, this non-matching point 
will be paired by any type of base: N (A, T, C, or G).   Thus, by this process, a base-G in a 
mother cell is randomly replaced by A, T, C, or G in grand-children cells. In this way, the Igs 
expressed in different centrocytes will have different motifs in variable regions, by which the 
cells have different affinities to an antigen.  
Ig molecules have five isotypes by structure, and they are IgM, IgE, IgG, IgD, and IgA. These 
isotypes have different Fc fragments in Ig heavy chain. Generation of an isotype of Ig is a 
result of class-switching recombination of Ig-Fc genes, which may occur in immunoblasts. In 
locus of IgH genes, there are eight candidate C-segments for making Fc genes: α, μ, ε, δ, γ1 
γ2a γ2b, and γ3 (segment).  Recombination of some of these segments and deletion of unneeded 
segments is essential for constructing a final Fc gene in a cell (Davila, 2001; Dadi, 2009). 
Different ways of recombination will result in generation of different forms of Fc genes. For 
example, the Fc gene for IgM has all of the eight C-segments: α, μ, ε, δ, γ1 γ2a γ2b, and γ3; that 
for IgG have six C-segments: α, δ, γ1 γ2a γ2b, and γ3; and that for IgA has only one α C-
segment.  As a result, different immunoblasts may produce different isotypes of Igs, although 
they may have the same antigen-specificity.  
3.4   Activation and differentiation of T-cells into immune cells in a LN 
Activation of a naïve T-cell needs two signals presented on an APC:  antigen-MHC complex 
and B7 proteins (CD80 and CD86). The first signal is recognized by TCR, namely MCH-II-
bound antigen is recognized by the TCR of CD4+ cells whereas MCH-I-bound antigen is 
recognized by the TCR of CD8+ cells. The second signal is recognized by CD28 on T-cells 
(Janeway, 2001). These combined signals then promote proliferation and differentiation of the 
T-cell. Finally, CD4+ T-cells differentiate into two types of effector cells and memory cells: 
antigen-specific regulatory T-cells (Treg cells) and T-helper cells (Th cells). CD8+ cells 
differentiate into antigen-specific cell-toxic T-lymphocytes (CTLs) and memory cells. 
Differently from that in B-cells, T-cells do not undergo somatic hypermutation during 
differentiation. Thus, a T-cell has less specificity and affinity to an antigen than a B-cell. In a 
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LN, the T-cells at different differentiating stages may all distribute in the paracortical zone. 
Probably, except T-immunoblast (?), all T-cells, including naïve cells, effector cells (Treg 
cells, Th cells, and CTLs), and memory cells, are small cells.  
3.5  Recirculation of lymphoid cells and homing tendency of memory cells  
LCs at different developing stages have different lifespans. A naïve lymphocyte and an 
effector cell can survive for only several days and a plasmablast may have a lifespan of 
several weeks. Differently, a memory cell can survive for several years. Importantly, memory 
cells are regenerable for our whole lifetime. By each time of secondary immune response, a 
memory cell can be re-stimulated to produce new effector cells and new memory cells. New 
memory B-cells may be produced also in a GC, where the cells can be again selected by 
antigen-affinity (Figure 2). Via lymph, some LCs, including effector cells, memory cells, and 
un-activated naïve lymphocytes, can reenter bloodstream and then redistribute in all LNs and 
LTs. This is called lymphocyte-recirculation.  A complete recirculation from a LN to the same 
LN takes 18-20 hours. By this recirculation, a LC can pass different organs and pass the same 
lymph organ many times. Lymphocyte-recirculation increases largely the opportunity for a 
lymphocyte to encounter an antigen.  
Although transported to all organs, memory cells have a tendency to return to the locations 
where they are activated by antigens (Gregor, 2017; Shin, 2017). The homing behavior of 
memory cells is mediated by homing receptors, which can recognize the addrssin molecules 
on endothelial cells (Mueller, 2013; Roy, 2002). These homing receptors include L-selectin, 
CLA, LFA-1, VLA-4, CD4, and LPAM-2.  They can bind respectively to the molecules of 
PNAD, E-selectin, ICAM-1, ICAM-2, VCAM-1, Mad, and CAM on endothelial cells. Due to 
this homing tendency, memory cells can be repeatedly reactivated by the same type of 
pathogens in infected tissues.   
IV. Repeated bone-remodeling during bone-growth and bone-repair may 
produce damage to marrow cells 
DNA changes are the trigger for cell transformation of a LC into a cancer cell. However, 
generation of DNA changes is a consequence of cell injuries and DNA injuries. Exploring the 
causes for cell injuries of LCs is thus critical for understanding leukemia and lymphoma. 
Exposure to radiation or chemicals such as that in radiotherapy and chemotherapy may be a 
causing factor for cell injuries of LCs. However, most patients with leukemia/lymphoma do 
not have experiences of radiotherapy, chemotherapy, or contacting with pesticides. We find 
out that, apart from unspecific environmental factors, LCs may have three “specific sources” 
of cell injuries: repeated bone-remodeling during bone-growth and bone-repair, for the HSCs 
and B-LCs in marrow; long-term thymic involution, for the developing T-cells in thymus; and 
repeated pathogen-infections, for the LCs in LNs/LTs. The third source is known, but the first 
two are our hypotheses. We will discuss the roles of these three factors in cell injuries of LCs 
respectively in this and next two parts. 
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B-cells are produced in bone marrow and T-cells are produced in thymus. Thus, the cell 
injuries of LCs that are associated with development of lymphoid leukemia should be mainly 
produced in marrow cavity. ALL occurs mostly before age 25, in the period of time when 
bones are growing. This phenomenon suggests that bone-growth may be related to ALL 
development. It is known that bone-growth is a result of repeated modeling-remodeling of 
bone tissues. Thus, it is quite possible that the repeated bone-remodeling during bone-growth 
produces occasionally damage to marrow cells.  
4.1 Formation of marrow cavity and spongy bone is a result of repeated modeling-
remodeling of bone tissues during bone-development 
Marrow cavity is the central cavity of a long tubular bone. The cavity is surrounded by 
contact bone as a long wall and by spongy bone at two ends. Spongy bone exists in the center 
of flat bones and in the two metaphysic parts of a long bone. Spongy bone is made by dense 
trabeculae. In a long bone, the lumen of marrow cavity and the tunnels of spongy bone are 
connected. Hematopoietic cells are produced in marrow cavity and the tunnels of spongy bone 
(Figure 3). Before age 40, most bones can produce blood cells. However, since age 40, blood 
cells are mainly produced in the spongy part of flat bones. It is observed that leukemia cells 
can invade into bone tissues in late stage of leukemia. Thus, it is quite possible that a change 
of structure or function of bone tissues affect hematopoietic cells. 
Marrow cavity and spongy bone are developed and enlarged with the growth of a bone. Bone 
development is achieved by two parallel processes: formation of new bone matrix (modeling 
of bone) by osteoblasts and absorption of unused bone matrix (remodeling of bone) by 
osteoclasts for reshaping the bone (Horton, 1990). Osteoblasts are produced by periosteum, 
but osteoclasts are produced by hematopoietic cells in marrow. A bone develops from a 
cartilage model. Ossification of the cartilage model starts from two ossification centers. The 
primary ossification center is located in center of the model, and it starts to produce bone 
tissues before birth of baby. The second center is located at two ends of the model and starts 
to work after birth of baby. Marrow cavity is developed from the primary ossification center 
by several steps. Firstly, new cartilage tissues need to be continuously produced from 
ossification center for enlarging the size of the cartilage model. New cartilage tissues are then 
modeled into bone tissues through adding bone matrix by osteoblasts. The outer parts of new 
bone tissues are then repeatedly modeled and remodeled to develop into compact bone. In the 
same time, the inner parts of new cartilage/bone tissues are gradually absorbed (remodeled) 
by osteoclasts, to develop into a cavity.  
Spongy bone is produced by the secondary ossification center of a long bone. Formation of 
spongy bone is a result of partial digestion of new cartilage/bone tissues by osteoclasts in the 
metaphyses of a bone. However, ossification of different bones starts at diffident ages. 
Ossification of big bones starts before birth, but that of small bones including flat bones and 
small long bones starts mostly after birth. However, all bones will have ossification centers 
before age 10. This suggests that the period of age 0-10 may be a peak time of formation of 
new marrow cavities and spongy bones. 
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Figure 3. Blood cells are produced in marrow cavity and the spongy part of a bone (a schematic graph) 
Hematopoiesis proceeds mainly in marrow cavity and the spongy part of a bone. Marrow cavity is the central 
cavity of a long tubular bone. The cavity is surrounded by contact bone as a long wall and by spongy bone at 
two ends. Spongy bone exists in the center of flat bones and in the two metaphyses of a long bone. Spongy 
bone is made by dense trabeculae. In a long bone, the lumen of marrow cavity and the tunnels of spongy bone 
are connected. Blood cells are produced in marrow cavity and the tunnels of spongy bone. During bone 
development, repeated remodeling of bone tissues is needed for reshaping the bone. Bone-remodeling of 
occurs to the part of bone exposed to cavity or tunnels. Bone-remodeling is a result of absorption of bone 
tissues by osteoclasts in marrow. Osteoclasts are produced by hematopoietic cells.  
 
Marrow cavity and spongy bone will be enlarged with the growth of a bone. A long bone 
grows in length and in thickness in the same time. Growth in length is a result of repeated 
additions of new cartilage tissues to metaphyses from epiphyseal plates. The outer part of new 
cartilage tissue is then modeled-remodeled into compact bone. The inner part is absorbed by 
osteoclasts and becomes a part of cavity. In this way, the cavity is enlarged gradually in 
length, and the lumen of spongy bone and that of marrow cavity join at metaphysis. 
Increasing of diameter of a long bone is a result of two processes: addition of new bone 
tissues beneath periosteum and absorption (remodeling) of old bone tissues that are exposed 
to cavity. In this way, the thickness of the bone is increased and the diameter of the cavity is 
as well enlarged. In the meantime, the spongy bone in metaphysis is also remodeled, reshaped, 
Compact bone 
Epiphyseal plate 
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and enlarged. Importantly, for bone-growth, the process of modeling-remodeling of bone 
tissues is repeating all the time in a child, for more than 20 years! 
4.2  Bone-remodeling occurs also during bone-repair and bone-adaptation  
In fact, bone-remodeling takes place also after bone maturation. To give a bone an adaptable 
resistance to external load, bone-remodeling may occur often to the compact bone and/or the 
spongy part of a bone. This adaptive bone-remodeling increases the potential of functionality 
of a bone and reduces the risk of bone fracture (Horton, 1990). However, bone injuries will 
occur anyway when a load exceeds the limit. Apart from visible fractures, a bone may have 
occasionally tiny injuries. In situations of bone injuries, bone-repair will be promoted for re-
linking bone tissue. Bone-repair is also a process of modeling-remodeling of bone tissues to 
rebuild the structure of part of a bone. A bone will have increased risk of injuries when it 
becomes osteoporotic and fragile at old age. Bone injuries and bone-repair have thus 
increased occurrences in old people. Therefore, bone-remodeling may have the highest 
frequency in two periods of time in our life: at young age (age 0-25) when the bones are 
growing; and at old age (age over 60) when the bones become fragile.  
4.3  Repeated bone-remodeling may produce toxic substances to hematopoietic cells in 
marrow 
Bone-remodeling is an essential process in bone-development and bone-repair. Remodeling of 
bone tissue occurs to the part of bone exposed to cavity or tunnel. Therefore, digestion of 
bone matrix by osteoclasts during bone-remodeling may produce damage to hematopoietic 
cells. An osteoclast absorbs bone tissue in three steps: A. the osteoclast adhere to the surface 
of the bone exposed to cavity (or tunnel); B. the osteoclast produce acid substances and 
enzymes including matrix metalloproteinases (MMPs) to digest local bone matrix; and C. the 
osteoclast enwrap and swallow the wastes of digested bone (Väänänen, 2000). Normally, this 
process is accurately controlled and may not affect neighbor cells.  However, if this process is 
disturbed somehow, the digestive substances may injure local hematopoietic cells (HCs). It is 
known that the children at age 2-5 have high incidence of bone fractures due to their fragile 
muscles and bones. Notably, a bone fracture or micro bone injury in a child may perturb the 
normal bone-remodeling for bone-growth. Thus, a child may have higher risk of injuries of 
HCs by (disturbed) bone-remodeling than other ages. In addition, for most small bones and 
flat bones, formation of marrow cavity occurs at age 0-10. This factor may also increase the 
risk of injuries of HCs by bone-remodeling in a child. There is a layer of fat tissue between 
bone tissue and bone marrow, and this fat tissue can protect HCs as a barrier. Nevertheless, 
the cells beneath bone trabeculae may have a risk to be injured by the aggressive substances 
produced during bone-digestion.  
V. Long-term thymic involution may produce damage to the developing T-cells in 
thymus  
Thymus is an organ for T-cell development. However, this organ undergoes involution since 
age of puberty. The weight of thymus is 15 g at birth and 35 g at age 11-13. Since puberty, 
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thymus starts to shrink by death of stromal cells. Finally, at age 50, most part of thymus is 
replaced by fatty tissues. It is known that T-lymphoblastic lymphoma/leukemia (T-LBL) 
originates from T-lymphoblast. 60%-80% of T-LBL patients have expanded mediastinal mass, 
indicating that the tumor of T-LBL may start from thymus.  T-LBL occurs mainly in 
adolescents and young adults, but rarely in old people. This suggests that the cell 
transformation of T-lymphoblast in T-LBL may be related to thymic involution. During 
thymic involution, death of stromal cells may release a great deal of enzymes and toxic 
substances. These substances, if not removed in time, may injure the developing T-cells 
(thymocytes). Although the risk of injury of T-cells in such a physical process is rare, long-
term and constant thymic involution can largely increase this risk.  
Taken together, repeated bone-remodeling and constant thymic involution may be two 
internal damaging factors for HCs, including HSCs, developing B-cells, and developing T-
cells. Cell injuries by internal damage can occur also to other cells including tissue cells 
during body-development and during inflammations. DNA changes can be also generated in 
some of injured tissue cells. However, for a tissue cell, cell transformation occurs mainly at 
old age, as a co-effect of external and internal damaging factors. Differently, a LC can be 
transformed at young age as that seen in ALL. Thus, the effect of internal damage on a LC 
can be recognized.  
VI. Repeated infections are the main cause for the cell injuries of LCs in LNs and 
LTs   
In lymphoma development, cell transformation of a LC is often an effect of multiple driver 
DNA changes. However, the last driver DNA change should be generated in the first 
transformed cell in a LN/LT. Exposures to toxic chemicals such as herbicides and pesticides 
may be a cause for DNA changes in LCs. However, for most patients who live in different 
environments, pathogen-infections should be more important in causing DNA changes in the 
LCs in LNs/LTs. Bacterial and viral can both damage LCs, but viral are more carcinogenetic, 
because viral can proliferate inside the host cells and damage the host DNAs directly.  
6.1  Three major types of pathogens associated with lymphoma development  
LNs are the locations where pathogens are trapped and filtered. The trapped pathogens in a 
LN can be removed by the high-concentrated immune cells, including effector LCs, 
granulocytes, macrophages, and NK cells. Our immune system has high efficiency on killing 
bacterial and extracellular viral, but it cannot remove all the viral that hide in a host cell.  
When an infection is severe or when our immunity is too low, excessive pathogens can 
damage the cells in LNs/LTs and in affected tissues. Bacterial can injure host cells by 
producing extoxin and endotoxin. Viral can damage a host cell via three pathways: adhesion 
to and lysing a host cell, self-multiplication in a host cell then lysing the cell, and integration 
of a viral DNA into a host DNA. Importantly, the viral hidden in a host cell can cut host 
DNAs on multiple points. Viral DNA can be inserted into a host DNA via DNA breaks. 
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Insertion of a viral DNA into a host DNA has two consequences for the host cell: DNA 
change and genome instability. 
Three types of pathogens are closely associated with lymphoma development, and they are 
Epstein-Barr virus (EBV), human T-cell lymphotropic virus type-1 (HTLV-1), and 
Helicobacte-Pylori (H. pylori). Human immunodeficiency virus (HIV) is also related to 
lymphoma development.  A patient with acquired immunodeficiency syndrome (AIDS) has 
high risk on developing lymphoma. However, the role of HIV in AIDS-related lymphoma is 
indirect, not by making DNA changes in LCs but rather by impairing T-cell-mediated 
immunity (Krishnan, 2014). In fact, different types of pathogens invade our body via different 
routes. The starting site of a lymphoma is determined by the type of pathogen.  
EBV is a type of DNA virus, and it spreads widely in the world. Most EBV-affected people 
are asymptomatic EBV-carriers (Geng, 2015). EBV has high affinity to B-LCs and 
nasopharyngeal epithelial cells. EBV is known to be associated with development of B-cell 
lymphoma, including Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), and 
Hodgkin’s lymphoma (HL) (Grywalska, 2015). EBV can hide in nasopharyngeal tissue and 
be transmitted via saliva. Mouth to mouth kiss may be an important transmitting route of EBV 
for human beings (Dunmire, 2015). Infectious mononucleosis (IM) is a diseases caused by 
EBV infection.  The kissing-habit in western countries may be related to the higher incidence 
of IM in young adults in these countries (Womack, 2015). EBV infects firstly the mucosa of 
digestive tract and that of airway. The neck LNs are responsible for collecting the lymph from 
mucosa of mouth and airway. Thus, in EBV infections, the LCs in neck LNs and that in 
mucosal LTs will be firstly affected by EBV. This explains why B-cell lymphomas start often 
from mucosa (in BL) or from the LNs in the neck-supraclavicular area (in HL).  
HTLV-1 is a type of retrovirus that has high infinity to mature CD4+ T-cells. Infection of 
HTLV-1 takes place only in some areas of the world, including Japan, Caribbean, South 
America, Iran, and Africa. HTLV-1 survives in bloodstream and tissue fluid in infected 
individuals. HTLV-1 is transmitted via sexual contact, breastfeeding, and blood transfusion. 
Although HTLV-1 infection is high in the above regions, only 5% of infected patients develop 
adult T-cell lymphoma/leukemia (ATLL) at adult age (Oliveira, 2017).  
H. Pylori are a type of bacteria that is associated with cancer development. H. pylori are a 
causing factor not only for stomach cancer but also for mucosa-associated lymphoid tissue 
lymphoma (MALTL) (Hu, 2016). Infection of H. pylori is common in all countries, and the 
infected patients have often chronic gastric ulcers. H. pylori can injure mucosal cells 
including epithelial cells and LCs. Long-term infection of H. Pylori is needed for MALTL 
development (Park, 2014).  H. pylori eradication is an effective pre-treatment for MALTL.  
6.2  Immunodeficiency: as a main causing factor for repeated pathogen-infections  
The pathogens that are related to lymphoma development have all high infection rates in 
population. However, only a small group of infected patients develop lymphoma. For example, 
90% of the people in the world are carriers of EBV, but the incidence rate of B-cell 
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lymphoma is only 0.01% in whole population (Grywalska, 2015). Infection of HTLV-1 
occurs in 10% of population in Japan, but only 5% of infected individuals develop ATLL. 
Hence, the patients who develop lymphoma may be those who have higher frequency of 
infections than others. It is rather the frequency of infections that is critical in lymphoma 
development. Except in big epidemic, repeated infections are often a consequence of short-
term or long-term immunodeficiency. Therefore, immunodeficiency contributes to lymphoma 
development probably by causing repeated infections. 
Immunity insufficiency of an individual can be caused by several factors. The most common 
factors are: A. insufficiency of nutrition in children and sick people; B. infection of pathogens 
which can weaken immune system, such as HIV and malarial parasites; C. immune 
suppression by medicaments such as that applied in autoimmune diseases or organ 
transplantations; and D. aging of organs in old people.   Hypo-immunity can have severe 
consequences. When pathogens cannot be cleared completely, they can invade into deep 
tissues even into bloodstream. Infections will occur repeatedly and chronically. The pathogens 
in large numbers can damage repeatedly LCs and tissue cells.  
In USA, the overall incidence of lymphoma has slightly declined since 2012 (Teras, 2016). 
However, in the past 50 years before 2012, the incidence of non-Hodgkin’s lymphomas 
(NHLs) was increasing in the world and in big cities (Skrabek, 2013). Several factors may be 
related to the increasing incidence of NHLs before 2012: increased populations in cities, 
increased usages of anti-inflammatory medicaments including aspirin, and increased rate of 
HIV-infection. Firstly, the people who live in big cities have increased risk of pathogen-
infections thus have increased risk of lymphoma development. Secondly, people are now used 
to take anti-inflammatory drugs for anti-pains or anti-fever since a long time. These 
medicaments may unfortunately suppress our immunity.  
Studies showed that long-term application of low-dose aspirin can reduce the risk of cancer 
development. Aspirin has this “anti-cancer” effect probably due to its role on inhibiting 
inflammation and tissue/cell repair. In our view, cell transformation in tumor-development is 
a result of accumulation of Misrepairs (mutations) of DNA (Wang-Michelitsch, 2015). 
Misrepair of DNA is a strategy of DNA repair when a cell has a severe DNA injury. However, 
aspirin can inhibit cell repair and DNA repair. Application of aspirin may result in failure of 
DNA repair (leading to cell death) rather than Misrepair of DNA (possible avoiding cell 
death). Thus for tissue cells, low-dose aspirin may slow down the accumulation of DNA 
mutations in cells and delay the occurrence of a cancer (Wang-Michelitsch, 2015). However, 
for LCs, aspirin may have an opposite effect. By inhibiting inflammations and 
immunoreactions, aspirin may increase the risk of cell injuries of LCs by pathogens. 
Therefore, aspirin may accelerate the accumulation of DNA changes in LCs and accelerate 
the occurrence of a lymphoma. 
It is known that AIDS patients have high incidence of lymphomas. The global number of 
AIDS-related death was increasing each year before 2005. However, due to the invention of 
effective drugs, the number of HIV-infection starts to decrease since 1999 and that of AIDS-
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related death is reduced since 2006 (Roser, 2017). Thus, the incidence of HIV-related 
lymphomas may have declined in recent years, and this may contribute to the slight decline of 
incidence of NHLs since 2012.  
In summary, apart from environmental factors, there may be three sources of damage that are 
more specific for LCs. They are: A. repeated bone-remodeling during bone-growth and bone-
repair, for the HSCs/LCs/MCs in marrow; B. long-term thymic involution, for the developing 
T-cells in thymus; and C. repeated infections of viral or bacterial, for the T-LCs and B-LCs in 
LNs and LTs (Table 1). Bone-remodeling may be associated with ALL development. Thymic 
involution may be related to T-LBL development. BL and ATLL are rather caused by 
pathogen-infections. 
 
Table 1. Three potential sources of cell injuries of lymphoid cells 
Locations Potential sources of damage Affected cells Associated LL/lymphoma 
In marrow cavity Repeated bone-remodeling during 
bone-growth and bone–repair 
HSCs, LCs, and MCs 
in marrow 
ALL (acute lymphoblastic leukemia) 
In thymus Long-term thymic involution Developing T-cells T-LBL (T-lymphoblastic lymphoma/leukemia) ? 
In lymph nodes and 
lymphoid tissues 
Infections of viral or bacterial B-LCs and T-LCs in 
LNs and LTs 
BL (Burkitt lymphoma) and ATLL (adult T-cell 
lymphoma/leukemia 
 
 
VII.   DNA changes in LCs are generated often as results of Misrepair of DNA on 
DNA breaks  
Modern sequencing techniques have made it possible to detect “all” the DNA changes in a 
cancer cell. However, only some of the DNA changes in a cancer cell contribute to cell 
transformation. Notably, in most forms of LL and lymphoma, the driver DNA changes in 
different patients are different. It would be too time-consuming and too expensive to study all 
the DNA changes in each patient. But one thing is clear: the more DNA changes a cell has, 
the higher risk has a cell on transformation.  Thus, for understanding cancer development, it is 
more important to study how DNA changes are generated in a somatic cell and how they 
accumulate in cells.  
7.1  Two types of DNA changes: point DNA mutation (PDM) and chromosome change 
(CC)  
Point DNA mutation (PDM) and chromosome change (CC) are the two major types of DNA 
changes. A PDM exhibits as alteration, deletion, or insertion of one or two bases in a DNA. A 
PDM can affect at most “one” gene, thus it is also called gene mutation or molecular mutation. 
For example, SOX11 mutation is found in 90% of mantle cell lymphoma (MCL) cases (Xu, 
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2010). Differently, a CC (also called cytogentic abnormality) can affect multiple genes. A CC 
can be numerical CC (NCC) or structural CC (SCC). A NCC exhibits as loss or gain of 
chromosomes of a cell. Major forms of NCCs include hyperdiploid, hypodiploid, aneuploid, 
loss of a chromosome (-), and trimosy (of chromosomes). For example, aneuploid is found in 
over 50% of ALLs (Al-Bahar, 2010; Braoudaki, 2012). Trimosy 8 is frequent in AMLs 
(Paulsson, 2007). A SCC exhibits as translocation (t), deletion (del), gain (+), or inversion 
(inv) of portion of a chromosome. For example, translocation t(8;14) is a main form of CC in 
Burkitt lymphoma (BL) (Cai, 2015), and t(2;5) is specific for ALK-positive anaplastic large 
cell lymphoma (ALK
+
-ALCL) (Fielding, 2012).  Notably, SCCs and NCCs are rare in cancers 
and sarcomas that arise from tissue cells, but not rare in leukemia and lymphoma. Different 
types of DNA changes are generated in cells by different mechanisms. Studies show that, 
PDM and SCC are generated as consequences of DNA breaks, but NCC is generated as a 
result of dysfunction of cell division. 
7.2  Generation of PDM: as a result of Misrepair of DNA on a double-strand DNA break  
On the mechanism of generation of PDM, there is still a debate. In our view, a PDM is neither 
an original DNA damage nor an error of DNA synthesis, but rather a result of Misrepair of 
DNA (Wang, 2009; Wang-Michelitsch, 2015). Studies have shown that Misrepair of DNA is 
the main source of PDMs (Natarajan, 1993; Bishay, 2001; Kasparek, 2011). A severe DNA 
injury including double-strand DNA break can promote SOS repair of DNA. One strategy of 
SOS repair of DNA is to re-link the broken DNA by non-homologous end joining (Rothkamm, 
2002; Iliakis, 2015). Such SOS repair is essential for preventing failure of DNA and death of 
cell; however it may result in Misrepair of DNA. Misrepair of DNA is thus a strategy for cell 
survival. However, the surviving chance of a cell by Misrepair of DNA is low. There are three 
reasons for that:  A. a cell that has DNA injuries may have also severe injuries on other parts 
of the cell; B. some DNA Misrepairs (mutations) are toxic to the cell; and C. a cell that is 
altered on phenotype by DNA mutations will be removed by immune system. Therefore, in 
situations of severe DNA injuries, most of injured cells will die, and only quite a few may 
survive by Misrepair of DNA. Thus, generation of PDM by Misrepair of DNA is a rare affair, 
and it is paid by death of many injured cells.  
7.3  Structural CC (SCC): generated as a result of Misrepair of DNA on multiple DNA 
breaks  
A SCC exhibits as deletion, translocation, or rearrangement of part of a chromosome. The 
altered part of a chromosome is often a DNA fragment that has been cut off from another 
chromosome by one or two DNA breaks. Chromosome translocation can be generated when a 
drop-off DNA fragment attaches incorrectly to another chromosome, which has also DNA 
breaks. Chromosome rearrangement can take place when a cut-off DNA fragment is reversed 
or recopied before being re-inserted back. Thus, generation of SCC is a consequence of DNA 
breaks. When there is only one DNA break in a cell, a PDM or deletion of part of a 
chromosome may occur. When there are multiple DNA breaks, PDM(s) and SCC(s) can be 
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both generated. In fact, most cells that have multiple DNA breaks will die from failure of 
DNA. Survival of a cell with a PDM or a SCC is a rare case.  
Since a PDM is generated as a result of Misrepair of DNA, generation of SCC should be also 
a result of Misrepair of DNA (Iliakis, 2015). Structural integrity of a DNA is essential for 
DNA function and for cell survival. Translocation or rearrangement of part of a DNA should 
be a result of re-linking of two DNA fragments. However, DNA re-linking can be achieved 
only by the DNA repair system of the cell, thus it is a result of DNA repair. DNA re-linking 
can be made by a direct end-rejoining of two DNA fragments, which may result in generation 
of a PDM. However, DNA re-linking can be also made via a “foreign” DNA fragment, which 
may result in generation of a SCC. The “foreign” DNA fragment can be: a 
translocated/inverted/recopied DNA fragment or a viral DNA fragment. Although part of 
DNA sequence is altered by such an incorrect re-linking of DNA, DNA integrity is 
maintained. Thus, a SCC is generated for cell survival. Insertion of a viral DNA into a host 
DNA is a type of SCC, thus it is also a result of Misrepair of DNA.  
7.4   Numerical CC (NCC): generated as a consequence of dysfunction of cell division  
NCCs such as hyperdiploid and hypodiploid are often seen in ALL cells. Generation of a 
NCC is a consequence of dysfunction of separation of homologous chromosomes during cell 
mitosis. This may occur when a dividing cell is injured. Most of the cells that are severely 
injured during cell division will die; however a few may survive with or without chromosome 
changes. A cell that is injured during cell mitosis can have different destinies in different 
situations. For example, if a cell is injured at phase S/G2 and DNA synthesis is interrupted, 
the cell will die.  If a cell is injured at M-metaphase, and chromosome separation but not cell 
body division is affected, a daughter cell can be born with gain or loss of chromosomes. If a 
cell is injured at M-telophase, and chromosome separation is not affected but cell body 
division fails, the cell will have double sets of chromosomes (tetraploid). Since gain or loss of 
one or more chromosomes may affect multiple genes, most of the daughter cells that are born 
with abnormal number of chromosomes will die. However, rarely, certain forms of NCCs can 
be non-fatal for a LC. Such forms of NCCs do not cause cell death but rather drive cell 
transformation. The aneuploid in ALL is an example. Importantly, in the organs of 
hematopoiesis (in marrow) and activation of lymphocytes (in LNs/LTs), a large number of 
developing cells are constantly in processes of cell division. These cells have high risk of 
injuries during cell division by damaging factors, thus they have a risk of generation of NCCs. 
A PDM/SCC is made for DNA repair for cell survival, thus generation of PDM/SCC is not 
really a mistake. Differently, a NCC is not generated for “repair”; thus survival of a cell with 
a NCC is a real mistake. Importantly, a NCC can affect multiple genes and may cause cell 
transformation rapidly. If such a mistake is not removed, the NCC may lead to death of the 
organism by causing cancer development. Some ALLs may develop as a consequence of such 
a mistake, because the cell transformation in these ALLs is made by aneupoid of 
chromosomes. 
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7.5  Pathogen-infection: as the main external source of DNA breaks for LCs in LNs/LTs 
Generation of PDM/SCC is a consequence of DNA breaks. The DNAs in a cell are protected 
in nucleus. Each DNA is hidden in its supercoli structure, which appears as a chromosome at 
phase M and as heterochromatin at phase G0. Only the activated parts of a DNA are 
temperately in relax (extended) state and not in supercoli structure. Thus, in a cell, DNAs 
have lower risk of injury than other parts of the cell. However, DNAs are sensitive to 
radiation, some types of chemicals, and viral. For the LCs in a LN/LT, infections of viral and 
bacterial are the main sources of DNA damage (Figure 4). Bacterial can injure host DNAs 
indirectly by extoxin and endotoxin. Viral have higher impact on host DNAs than bacterial. 
Viral can enter, hide, and proliferate in host cells, thus they can attack host DNAs directly. 
The viral in large numbers in a host cell can cut host DNAs frequently at different points. Not 
protected in supercoli structure, the activated parts of a DNA are more sensitive to viral-
attacking than other parts. All the LCs that have passed a LN/LT may have a risk of DNA 
breaks by viral attacking. Differently, the developing LCs in marrow cavity and in thymus, 
including lymphoblasts and pro-lymphocytes, may have lower risk of DNA breaks. 
 
 
 
 
 
 
 
 
 
Figure 4. A PDM/SCC is generated as a consequence of DNA breaks in a cell 
DNA breaks are the triggers for generation of PDM or SCC. Apart from pathogen-attacking and 
radiation/chemicals, bone-remodeling and thymic involution may be two internal sources of DNA breaks for 
LCs. DNA rearrangement of Ig/TCR genes may also introduce DNA breaks in a LC. A broken DNA must be re-
linked for maintaining the structural integrity of DNA and for preventing cell death. However, if a broken DNA is 
re-linked by a wrong base, a PDM can be generated. If a broken DNA is re-linked by a foreign DNA fragment, a 
SCC can be generated. Thus, a PDM/SCC is generated as a consequence of DNA breaks in a cell.  
 
7.6  DNA rearrangements of Ig/TCR genes may also introduce DNA breaks in a LC 
DNA rearrangements of 
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DNA breaks are the triggers for generation of PDM or SCC. However, DNA breaks can be 
introduced in LCs not only by external damage but also possibly by DNA rearrangements of 
Ig/TCR genes. For producing immune cells that have large diversity on recognizing antigens, 
a lymphocyte undergoes three processes of “treatments” of Ig/TCR genes before becoming an 
immune cell. These three processes are: A. DNA rearrangement of V (D) J segments for the 
genes that code the variable regions of IgH/TCR, occurred in lymphoblasts; B. somatic 
hypermutation in the genes that code the variable regions of IgH, occurred in centroblasts; and 
C. class-switching recombination of DNA segments for the genes that code the Fc region of 
IgH, occurred in B-immunoblasts (Davila, 2001; Dadi, 2009). In processes A and C, certain 
DNA segments in loci of IgH/TCR genes needs to be cut off at first, and then the remaining 
parts of DNA need  to be re-linked.  Thus, in processes A and C, DNA breaks are introduced 
transiently (Figure 4). 
In process B, hypermutation begins by modification of a base-C into a base-U in the locus of 
genes for the variable region of IgH. The “head” of base-U is then removed, leaving a non-
paired point “facing” to the base-G in complementary strand. In subsequent DNA replication, 
this non-matching point will be paired by base N (A, T, C, or G). By this process, a base-C at 
this point in a mother cell is randomly replaced by A, T, C, or G in grand-children cells. 
However, in some cells, the locus of IgH gene have still non-paired base at this point. A non-
paired base makes separation of two complementary strands of DNA at this point, which may 
affect the structural stability of the DNA. Thus, somatic hypermutation may make the part of 
DNA coding IgH have increased risk of DNA breaks.  
Normally, the DNA breaks introduced in these processes can be closed quickly and correctly. 
However, if a cell is injured during one of these processes, incorrect re-linking of DNAs may 
take place, and a PDM or a SCC can be generated. For example, the t(8;14) in BL is possibly 
generated as a consequence of three DNA breaks in a centroblast (Cai, 2015). One DNA 
break (break A) occurs to the locus of IgH gene in chromosome 14, which may be related to 
somatic hypermutation of Ig gene. Two other breaks (break B and C) occur to chromosome 8, 
which may be related to viral attacking. If, by chance, DNA breaks B and C result in releasing 
of a DNA fragment containing MYC gene, MYC-translocation may occur. If the MYC-
containing DNA fragment is unfortunately inserted into the locus of Ig gene by DNA break A, 
t(8;14) can be generated. Notably, a DNA translocation to the locus of Ig/TCR gene can have 
severe consequences. In a LC, Ig/TCR genes are constantly expressed. Thus, a gene that is 
translocated to the locus of an Ig/TCR gene can be constantly expressed or over-expressed by 
the promoter of Ig/TCR gene. Most LCs may be not able to survive from such a translocation. 
For example, the IgH-MYC translocation in t(8;14) results in over-expression of MYC, which 
may drive the cell transformation of a centroblast in BL development. In T-LBL, the most 
frequent DNA changes are the translocations of transcription factor genes to the loci of TCR 
genes, such as t(7;9), t(1;14), and  t(10;14). Such a translocation results in over-expression of 
a transcription factor and independent cell proliferation. A translocation to the locus of a TCR 
gene is quite possibly related to the DNA rearrangement of TCR genes during the 
differentiation of T-lymphoblast.  
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Taken together, there may be three groups of sources of DNA breaks for LCs: A. external 
radiation/chemicals and pathogen-attacking; B. internal bone-remodeling and thymic 
involution; and C. DNA rearrangements of Ig/TCR genes (internal) (Figure 4). Reparation of 
DNA breaks results in generations of PDMs and/or SCCs in LCs. Thus, repeated bone-
remodeling, thymic involution, and pathogen-infections may all contribute to the enlargement 
of the reservoir of DNA changes in LCs with age of the body. 
7.7 Repeated cell injuries and cell proliferations drive the accumulation of DNA changes 
in LCs 
It is rare that “one” DNA change promotes cell transformation. Cell transformation is often a 
result of accumulation of many driver DNA changes. Most PDMs and some tiny SCCs are 
silent or mild to a cell, thus they can survive and accumulate in cells. A PDM/SCC is 
generated as a result of Misrepair of DNA on DNA breaks. However, a somatic cell has quite 
low opportunity to survive two times from severe DNA injuries. Thus, DNA changes cannot 
accumulate in “the same” cell, but only possibly in some of its offspring cells. Accumulation 
of Misrepairs of DNA needs to proceed in many generations of cells (Wang-Michelitsch, 
2015).  
Accumulation of DNA changes is a result of repetition of a circle of three processes: cell 
injuries and DNA injuries; survival of one of the injured cells by Misrepair of DNA and 
generation of PDM/SCC; and proliferation of this cell. Thus, accumulation of DNA changes 
is a slow process through many generations of cells. Repeated cell injuries are the triggers for 
generation of DNA changes, and repeated cell proliferation enables the accumulation of DNA 
changes in cells. For example, in a LN/LT, pathogen-attacking can trigger generation of DNA 
changes in a LC, and repeated proliferation of LCs promoted by pathogens enables the 
accumulation of DNA changes in memory cells and other LCs. In marrow cavity, repeated 
bone-remodeling may trigger generation of DNA changes in a HSC or a LC, and regeneration 
of HSCs and proliferation of developing LCs enable the accumulation of DNA changes in 
HSCs and LCs. 
7.8  Long-term accumulation of DNA changes occurs mainly in HSCs and memory cells 
DNA changes can accumulate in HSCs and LCs at any developing stage. However, a long-
term accumulation of DNA changes can occur only in long-living stem cells. HSCs are stem 
cells regenerable for our whole lifetime. Memory cells are long-living immune cells that can 
be regenerated at each time of secondary immune response. Thus, among all DNA changes, 
only those generated or inherited in HSCs and memory cells can accumulate for a long time. 
The DNA changes in other LCs, if not inherited by memory cells, will disappear by death of 
the cells. For example, a DNA change generated in an effector cell will disappear when the 
cell dies. 
Although accumulation of DNA changes takes place mainly in HSCs and memory cells, all of 
their offspring cells can inherit the DNA changes. A LC can have all the DNA changes of its 
precursor stem cells and other precursor LCs. For example, a naive lymphocyte can inherit the 
 Email : thomasjicun@gmail.com 26 
 
DNA changes generated in its precursor HSCs, lymphoblasts, and pro-lymphocytes. An 
effector cell can inherit the DNA changes generated its precursor HSCs, memory cells, and 
other precursor LCs. The accumulated DNA changes in HSCs and memory cells may 
contribute to cell transformation of any one of their offspring cells. Thus, the driver DNA 
changes for lymphoma development may be partially produced in the HSCs/LCs in marrow 
and partially in memory cells and LCs in LNs/LTs.  
7.9   Accelerated accumulation of DNA changes in transformed LCs   
Many forms of CCs (cytogenetic changes) and PDMs (molecular mutations) have been 
observed in leukemia cells and lymphoma cells. However, a big part of them might be only 
secondary DNA changes. Namely, they are the DNA changes that are generated after the 
occurrence of cell transformation of a normal cell into a tumor cell. Secondary DNA changes 
are not responsible for the occurrence of a cancer, but they may drive the further procession of 
a cancer and affect cancer prognosis.  Secondary DNA changes are often seen in late stage of 
a cancer. For example, gain or loss of an arm of chromosome, such as (+1q), (+7q), del (6q), 
del (13q), and del (17p), is often seen in later stage of MCL, chronic lymphocytic leukemia 
(CLL), and diffuse large B-cell lymphoma (DLBCL) (Royo, 2011; Grange, 2017). Complex 
karyotypes may be often secondary DNA changes in some lymphomas (Cohen, 2015). 
Generation of a secondary DNA change in a tumor cell is also a consequence of cell injuries 
and DNA injuries. However, the injuries of tumor cells may be often caused by the necrosis 
of some cancer cells due to lack of nutrition.  
Importantly, accumulation of secondary DNA changes in neoplasm cells is self-accelerating 
and in-homogenous (Wang-Michelitsch, 2015). Three factors may contribute to this self-
acceleration: A. frequent cell divisions of neoplasm cells; B. chromosomal instability in 
neoplasm cells caused by DNA changes; and C. increased tolerance of neoplasm cells to 
DNA changes because of poor cell differentiation. However, different neoplasm cells may 
have different secondary DNA changes, which lead to the heterogeneity of cancer cells. The 
cancer cells having different genetic backgrounds can be different to each other by 
morphology, behavior, and sensitivity to cancer therapy. This explains the treatment-
resistance in late-stage cancers. Some secondary DNA changes can transform a well-
differentiated neoplasm cell into a poor-differentiated one, which results in transformation of 
an indolent tumor into an aggressive cancer. In a tumor, if some tumor cells grow faster than 
others by some secondary DNA changes, they may become the so-called “tumor stem cells” 
(Martinez-Climent, 2010). A “tumor stem cell” may proliferate more quickly than other tumor 
cells; however, only a small group of cells in a tumor are produced by this “tumor stem cell”. 
Therefore, a targeted treatment that takes “the tumor stem cells” as killing target cannot be 
very effective.  
VIII. Conclusions 
We have discussed in this paper the potential sources of cell injuries of LCs and the 
mechanism of generation and accumulation of DNA changes in LCs. The DNA changes in 
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LCs contributing to development of LL/lymphoma can be generated in marrow, thymus, 
and/or LNs/LTs. In LNs/LTs, pathogen-infections may be the main cause for cell injuries of 
LCs. In marrow cavity, repeated bone-remodeling during bone-growth and bone-repair may 
be a source of cell injuries of HSCs and developing LCs. In thymus, long-term thymic 
involution may produce damage to the developing T-cells. Generation of DNA changes is 
often a result of Misrepair of DNA on DNA breaks. DNA breaks can be introduced not only 
by external damage but also possibly by DNA rearrangements of Ig/TCR genes.  Repeated 
cell injuries and repeated cell proliferation drive the accumulation of DNA changes in HSCs 
and LCs. Long-term accumulation of DNA changes occurs mainly in HSCs and memory cells.  
To verify our hypothesis that bone-remodeling and thymic involution may be related to cell 
transformations of developing LCs, experimental researches can be undertaken to study 
respectively the associations of repeated bone injuries and repeated thymic injuries with the 
development of leukemia in animal models (such as rabbits).  
It is sad when LL/lymphoma occurs in a child or an adolescent. Our analysis indicates that 
development of pediatric LL/lymphoma may be related to bone-growth and thymic involution. 
However, these two risk factors are unfortunately internal and unavoidable. In addition, 
immunodeficiency is a risk factor for both children and adults. Thus, to reduce the risk of 
occurrence of LL/lymphoma, we have two suggestions: avoiding violent sports and reducing 
the usage of anti-inflammation medicaments. Cryo-preserving the HSCs in umbilical cord at 
birth is advised for the whole population.  
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